💗Atrial cardiomyopathy is a novel clinical entity with important clinical implication 🔥
🚨Check out our new editorial addressing this issue!
🔗👇https://t.co/iMrXOdRCY5
Original paper 👇
https://t.co/FYW4Qh2SSk
@JacopoImberti@marcovitoloMD@GiuseppeBoriani
Comparing Outcomes in Asymptomatic and Symptomatic Atrial Fibrillation: A Systematic Review and Meta-Analysis
👥81,462 pts
↔️No differences: all-cause death, CV death and stroke
@BorianiGiuseppe@MProiettiMD@UNIMORE_univ@LiverpoolCCS
https://t.co/ldvQgW3QQT @JCM_MDPI
MASCOT HIT Study Published!!
https://t.co/mEqNOgoqgh
26 Centers, 3 years of work, How to measure LA strain?
Let me thank All Investigators, Steering Committee and Board Members that allow this great achievement!!!!
Dedicated to the Memory of Prof. Maurizio Galderisi.
The SCD-HeFT randomized 2,521 patients with moderate #heartfailure to amiodarone, placebo drug, or #epICD. What are the long-term outcomes of ICD therapy in the SCD-HeFT patients? This week's #JACC provides the answers: https://t.co/HwFwE8gk8Y @jepoolemd
Excellent @JACCJournals review on the use of #cvimaging for Myocardial Tissue Characterization & fibrosis
🧲Concept of 2 types of #fibrosis: Interstitial and replacement
🧲Myocardial #fibrosis associated with poor prognosis